Scientific publisher Nature Publishing Group (NPG), UK, and BioCentury Publications, Inc., US, have unveiled SciBX, a new publication that seeks to leverage the business intelligence of BioCentury and the scientific acumen of NPG. SciBX will distill and analyse newly published life science research, aiding the translation of academic science into commercial products.
The Preview Edition of SciBX: Science-Business eXchange was launched during the 26th Annual JPMorgan Healthcare Conference in San Francisco. The electronic publication will be distributed to SciBX subscribers every Thursday, starting January 31, 2008. The companies also announced the launch of www.scibx.com, a new website featuring a free Preview Edition of SciBX and information on the publication and charter subscription rates.
SciBX will evaluate hundreds of high impact peer-reviewed scientific articles every week and pick the most commercially relevant findings that merit deeper analysis. Such a multidisciplinary approach is expected to provide scientific context, identify potential commercial impact and describe the next steps required to translate the newest developments in the lab into innovative healthcare solutions.
The biopharmaceutical industry and its investors are inundated with complex scientific papers describing the latest discoveries each week. According to MEDLINE, over 600,000 articles were added to its database in 2006 alone. The new publication is expected to help distill this flood of scientific data by filtering and analysing key findings within the most current scientific and business context. It is projected as a resource for biotechnology and pharmaceutical executives, business development specialists, drug discovery and development teams, venture capitalists and other investment professionals who wish to identify new projects and potential new partners.
More News in this Theme
